ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has appointed Oksana S. “Sandy” Dominach as an independent director to its Board. Ms. Dominach brings more than 32 years of experience and expertise in financial strategy, risk management and treasury, as well as over ten years of experience participating on a variety of public and non-for-profit boards. She is currently the Senior Vice President & Treasurer at Constellation Brands, Inc. (NYSE: STZ), a leading international producer and marketer of beer, wine and spirits.
“Sandy is a seasoned strategic business leader, with particular expertise in capital structure management, risk management, corporate compliance and shared service," said Charles P. Hadeed, Transcat’s Chairman of the Board. "We are delighted that she is bringing her insight and acumen to our Board as we continue to advance our growth strategy."
Ms. Dominach has been with Constellation for 16 years, participates at the Board and Audit Committee level, leads development and management of their overall risk management strategy, is a member of Constellation’s Disclosure Committee and has been the strategic lead in various acquisitions and divestitures. She successfully led Constellation’s $4 billion investment in Canopy Growth, the largest investment in the legal cannabis space through the U.S. bank and public markets at the time of such investment.
Prior to that, she spent 14 years with Gleason Corporation, a leader in the development, manufacture and sale of gear production machinery and related equipment and automation solutions.
Ms. Dominach currently serves as Treasurer and Director of the non-for-profit Board of Constellation – Marvin Sands Performing Arts Center; is a Director of the Directors Advisory Council of the Rochester Division of Manufacturers and Traders Trust Company, and serves as a director on a number of internal boards at Constellation, as well.
With the appointment of Ms. Dominach, Transcat’s Board of Directors consists of ten members.
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, including life science, aerospace and defense, pharmaceutical, medical device manufacturing and biotechnology. Transcat provides permanent and periodic on-site services, mobile calibration services and in-house services through 21 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.
Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise and integrity create a unique and compelling value proposition for its customers.
Transcat’s strategy is to leverage the complementary nature of its two operating segments, its comprehensive service capabilities, strong brand, enhanced e-commerce capabilities and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize its inherent leverage of its business model.
More information about Transcat can be found at: Transcat.com.
Safe Harbor Statement
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and assumptions. Forward-looking statements are identified by words such as “expects,” “estimates,” “projects,” “anticipates,” “believes,” “could,” and other similar words. All statements addressing operating performance, events or developments that Transcat, Inc. expects or anticipates will occur in the future, including but not limited to statements relating to anticipated revenue, profit margins, the commercialization of software products, sales operations, capital expenditures, cash flows, operating income, growth strategy, segment growth, potential acquisitions, integration of acquired businesses, market position, customer preferences, outlook and changes in market conditions in the industries in which Transcat operates are forward-looking statements. Forward-looking statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Transcat’s Annual Report and Quarterly Reports filed with the Securities and Exchange Commission, including under the heading entitled “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of the Company’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company’s forward-looking statements. Except as required by law, the Company disclaims any obligation to update, correct or publicly announce any revisions to any of the forward-looking statements contained in this news release.
